Related Experiment Video
Updated: Jan 26, 2026

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease
Gillian A Durham1, Jamie J L Williams2, M Talat Nasim1
1Pharmacology and Experimental Therapeutics Research Group, School of Pharmacy and Medical Sciences, University of Bradford, Bradford BD7 1DP, UK.
None:
Defective regulation of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signalling pathway in cancers, haematological diseases, and chronic inflammatory conditions highlights its clinical significance. While several biologic and small molecule therapeutics targeting this pathway have been developed, these have several limitations. Therefore, there is a need to identify new targets for intervention. Suppressor of cytokine signalling (SOCS) proteins are a family of inducible inhibitors of cytokine receptors that activate the JAK-STAT pathway. Here we propose that newly identified mechanisms controlling SOCS function could be exploited to develop molecularly targeted drugs with unique modes of action to inhibit JAK-STAT signalling in disease.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Endocrine Signaling
What is Cell Signaling?
Yeast Signaling
Paracrine Signaling
Bacterial Signaling

